Agendia BV, a world leader in the rapidly evolving field of cancer molecular diagnostics has appointed six members to its Clinical and Scientific Advisory Board. The newly established Clinical and Scientific Advisory Board is comprised of internationally-recognized scientists with research and clinical expertise. The advisors review early research programs and provide critical evaluations from academic and clinical perspectives.
